It is well-known that hypotension is often accompanied by habu (Trimeresurus flavoviridis) bites, particularly in severe cases (1, 2) . Previous investigations on the hemo dynamic effects of habu venom have con sistently demonstrated that the intravenous injection of the venom produces a fall in blood pressure in rabbits, dogs, mice and rats (3-6). The following have been supposed to be possible causes for the hypotension: both myocardial depression and dilatation of blood vessels (4, 5), unknown endogenous sub stances produced by habu venom (3, 5) or histamine which has been shown to be re leased by the myonecrotic factor separated from crude habu venom (6). On the other hand, our previous study suggested that the heat-stable component (s) of habu venom in cluding phospholipase A2 might relate partly to the dilatation of coronary vessels in isolated and perfused rat hearts (7). However, the precise mechanisms for hy potension or hemodynamic changes induced by habu venom have not yet been established. The present study was, therefore, undertaken to evaluate in detail the effects of habu venom on the cardiovascular system both in vivo and in vitro and to clarify pharmacologically the mechanisms of actions.
Materials and Methods In vivo experiments:
Male Wistar rats weighing 250-360 g were anesthetized with pentobarbital sodium (60 mg/kg, i.p.), and the four limbs were secured to a board in a dorsal position. In order to measure aortic pressure (AoP), a polyethylene catheter (Clay-Adams, PE50) filled with physiological saline containing heparin (100 U/ml) was inserted into the aorta through the right carotid artery, and this was connected to an electric manometer (Statham, P231D).
The surface of the left kidney was exposed via an incision in the lateral surface of the abdomen. The tip of the fiber optic laser Doppler flowmetry (LDF) probe (TSI, model P430-ST) was placed in contact with the renal cortical surface. The probe was con nected to LDF measuring units (TSI, model BPM 403) capable of generating a 780-nm laser beam and analyzing the light scattering back from tissue. With the use of the signal averaging time of 5 sec, the analog voltage output signals of renal cortical blood flow (RCBF) were continuously recorded. The relationship between displays of RCBF (ml/ min/100 g) and the analog output tracings (V) was found to be linear (8, 9). In the present study, one volt in the analog output tracings corresponded to 80 ml/min/100 g in the displays of RCBF. Thus, in this study, RC B F was measured to know the state of the peripheral circulation.
Heart rate (HR) was counted by means of a cardiotachometer (Nihon Kohden, AT 600G) triggered by the R-wave of an electro cardiogram (lead-II). The left femoral vein was cannulated with a polyethylene tube and was infused with physiological saline at a rate of 10 /cl/min by means of an infusion pump (Harvard, Model 975) throughout the experi ments. Drugs were injected into the femoral vein via this tube in a volume of 1 ml/kg body weight.
Responses of diastolic AoP (d-AoP) to angiotensin 11 (ANG II, 100 ng/kg) and acetylcholine (ACh, 0.5 gig/kg) were ex amined at the beginning and the end of the experiments to estimate the effect of habu venom on the vascular responsiveness to these agonists. The validity of the measure ment of d-AoP was verified by the occurrence of the immediate rise and fall in d-AoP follow ing ANG II and ACh, respectively.
All measured variables were recorded on an 8 channel pen-writing recorder (Nihon Kohden, WT-685G).
In vitro experiments: Thoracic aortae of male Wistar rats (250-360 g) were removed under pentobarbital anesthesia, and the aortic ring preparation (about 2 mm length) was mounted between hooks and placed in an organ bath containing 20 ml Krebs-Henseleit solution maintained at 37'C and bubbled with 95% 02 and 5% CO2. The composition of Krebs-Henseleit solution was as follows: 120.0 mM NaCI, 4.8 mM KCI, 1.25 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgCl2, 25.0 mM NaHCO3, and 5.5 mM glucose. The isometric tension was measured by a force-displace ment transducer (Nihon Kohden, TB-611T or SB-1T) attached to a polygraph (Nihon Kohden, RJG-4004).
A resting tension of 0.5 g was applied to the preparation, which was then allowed to equilibrate for 90 min. The aortic ring preparation was contracted with 3X10-' M norepinephrine (NE) or 30 mM KCI. Habu venom was added to the organ bath 15 min after application of NE or KCI. The difference between the individual maxi mal tension produced by N E or KCI and the individual minimal tension produced by papaverine (10-4 M) was difined as 100%, and the change in tension elicited by habu venom was expressed as a percentage. In other preparations, the tissue was exposed to inhibitors 50 min before NE addition. Denuda tion of the endothelium was carried out by rubbing the luminal surface of each ring with a plastic tube. The absence of the endothelium was confirmed by failure to exhibit a relaxing response to ACh (10-6 M) before the addition of habu venom.
Estimation of phospholipase A activity: The phospholipase A (PL-A) activity in habu venom was estimated by the method of Habermann and Neumann (10), which is based on the fact that PL-A inhibits heating induced coagulation of egg yolk. Habu venom was dissolved in 0.04 M veronal buffer (0.04 M barbiturate-HCI, pH 7.0). Each sample of 0.2 ml was mixed with 0.8 ml of 50% egg yolk dissolved in 0.04 M veronal buffer. Final concentrations of habu venom and standard PL-A2 which is derived from Crotalus durissus terrificus venom, were both 10-4 g/ml. After incubation for 30 min at 37'C, the mix ture was placed in a boiling bath, and then the coagulation time of each sample was meas ured.
Materials Heated habu venom was obtained as fol lows: the habu venom solution was heated at 70°C for 5 min, and then it was centrifuged at about 3000 rpm for 1 5 min. The supernatant was used as heated habu venom.
The dialyzed habu venom (0.4 mg/ml) was obtained by dialyzing the venom preparation in seamless cellulose tubing (type 8/32, Visking Company) against 0.02 M phosphate buffer (pH 7.3) for 5 hr at 4°C. The exclusion limit of the tubing was 10,000 Da.
Data analysis: Data were analyzed by analysis of variance or Student's t-test. A P value of less than 5% was defined as the level of statistical significance. All data were rep resented as means±S.E. Results Hemodynamic effects of habu venom: As shown in Fig. 1 , an intravenous injection of 0.4 mg/kg of habu venom caused an apparent fall in AoP and a decrease in RCBF without a marked change in HR. The changes in AoP and RCBF recovered gradually to the control level until 30 min after the injection. As shown in Fig. 2 , the degrees of hypotension produced by 0.2 to 1.6 mg/kg of habu venom were dose-dependent.
The maximum changes in AoP were seen between 3-5 min after the in jection. H R did not significantly change, and 
RCBF decreased
along with the decline in AoP. All rats that received the venom at the dose of 0.2 to 0.8 mg/kg survived during the 60 min observation period, but one of the four rats expired 20 min following the in jection of 1.6 mg/kg of habu venom. When 0.8 mg/kg of habu venom was repeatedly administered at an interval of 60 min, the hypotensive effect significantly attenuated and the decrease in RCBF disappeared (Fig.  3) . On the other hand, the administration of habu venom (0.4 mg/kg) did not signifi cantly change the pressor response to ANG-II (before the venom: 27.8±1.1 mmHg and after the venom: 31.5±2.5 mmHg) and the depressor response to ACh (before the venom:
-44.9±1.8 mmHg and after the venom: -45.7±1.4 mmHg), indicating that the vascular integrity, at least in the respon siveness to these agonists, is probably pre served even after the venom treatment. which were given 30 min, 5 min and 10 min before the venom in jection, respectively (Table 1 ) . Pretreatment with aprotinin (10,000 IU/kg, i.v. + 1,000 IU/ kg/min, n=4) or chlorpheniramine (1 mg/kg, n=2) also did not affect the hypotensive ac tion of habu venom (data are not shown). Heated habu venom as well as the non heated one produced a fall in AoP and a de crease in RCBF. On the other hand, in rats treated with 120 1 U/kg of habu antivenin, i.v., the peak values of both hypotension and de crease in RCBF produced by habu venom were significantly depressed as compared with those observed in control rats (Table 1) . Treatment with methylprednisolone (60 mg/ kg, i.v.) 90 min before the venom injection significantly reduced changes in systolic AoP (s-AoP), d-AoP and RCBF as seen in Fig. 4 .
Effects of dialyzed habu venom: The effects of dialyzed habu venom (0.4 mg/kg) on hemodynamic changes were examined in two rats. The residual venom caused a comparable degree of hypotension (falls in s-AoP and d AoP were -45% and -48%) to that produced by the same dose of crude venom (Table 1) , while the dialysate did not have any hemo dynamic effect.
Effects of habu venom on isolated aortic ring preparations:
Non-heated habu venom (10-5 to 3X10-4 g/ml) caused dose-depend ent relaxations of the aortic ring preparations precontracted with N E (3x10-7 M) or KCI (30 mM) (Fig. 5A ). As shown in Fig. 513 , heated habu venom (70°C for 5 min) also produced a decrease in tension as well as non heated venom. Relaxations by 10-4 and 3 x 10-4 g/ml of heated habu venom were greater than those by the same doses of the non heated one (P<0.05 and P<0.01, respec tively). Effects of inhibitors of eicosanoids produc tion on relaxant responses to habu venom: To investigate the possible involvement of eicosanoids in the vascular relaxations in duced by habu venom, the effects of inhibi tors of cyclooxygenase (indomethacin), lipoxygenase (NDGA) and PL-A2 (mepacrine and p-BPB) on the venom-induced vasore laxations were examined (Fig. 6) . Aortic ring preparations were preincubated with indo methacin (10-5 M), NDGA (3X10-5 M), me pacrine (MEP, 10-5 M) or p-BPB (3X10-6 M) for 50 min before the challenge of habu venom. As shown in Fig. 6 , none of these in hibitors had any significant effect on the maximum tension decrease caused by non heated habu venom or that by the heated one (10-4 g/ml). Effects of removal of endothelium on vascular relaxation by habu venom: The re laxant effects of habu venom in paired prep arations from the same aorta with or without endothelium were compared. The endothe lium-denuded preparations failed to respond to ACh but still showed relaxant responses to habu venom (Fig. 6) . Pretreatment with methylene blue (10-5 M) also did not reduce the relaxant responses (data are not In the case of NDGA, the preparations were contracted with 3x10-6 M NE, since NDGA may have a non-specific depressant effect on NE-induced contraction.
The difference between the individual maximal tension produced by NE and the individual minimal tension produced by papaverine (10-4 M) was defined as 100%, and the change in tension elicited by habu venom was ex pressed as a percentage.
Each column indicates the mean±S.E. of 3-8 experiments. Table 2 . Effects of habu venom, phospholipase A2 inhibitor (p-BPB) and antivenin on heating-induced coagulation time of egg yolk shown). Phospholipase A activity: By addition of non-heated habu venom, heated habu venom or standard PL-A2, the coagulation time of egg yolk was markedly prolonged from less than one minute of the control coagulation time to over 25 min ( Table 2 ), indicating that both non-heated and heated habu venom have a PL-A-like activity. The prolonged coagulation time by the non-heated venom, that by the heated venom and that of standard PL-A2 were all shortened by addition of p BPB, a specific inhibitor of PL-A2. Habu anti venin also shortened the prolonged coagula tion time due to the non-heated habu venom or the heated one, but did not affect prolonga tion of the coagulation time in the case of standard PL-A2 (Table 2) .
Discussion
In the present experiments, an intravenous administration of habu venom induced signifi cant and dose-dependent decreases in AoP and RCBF without a marked change in HR. The hypotensive effect of habu venom in various experimental animals has already been demonstrated in earlier studies (3-5), and reduction of renal blood flow associated with marked hypotension after administra tion of the venom (2 mg/kg) in anesthetized dogs was also reported by Mineshita et al. (6) . In regard to the decrease in RCBF, it was considered that a fall of the perfusion pressure in the renal cortex due to the hypotensive effect of habu venom would be primarily re sponsible for the RCBF reduction.
Nuki et al. reported that the cardiac move ment of anesthetized rabbits and dogs meas ured with a cardiotambour was strongly de pressed when an extremely large dose of habu venom (15 mg/kg) was given (4). Further more, depression of myocardial contraction induced by a relatively large amount of habu venom (more than 1.5x 10-4 g/ml) was pre viously shown in isolated hearts of frogs (3, 5) and rats (5). In contrast to the case of a large dose of habu venom, a small dose of the venom has been reported to produce no cardiac effect or slight augmentation of myocardial contraction in anesthetized dogs (0.5-1.0 mg/kg) and rabbits (0.5 mg/kg) and in isolated perfused rat hearts (5X10-5-10-4 g/ml) (3-5, 7). Thus, at least in the dose range (0.2-0.8 mg/kg) employed in this study, the role of the cardiodepressor effect of habu venom, if any, seems not to be impor tant in the hypotensive effect. Alternatively, it seems reasonable that the habu venom induced hypotension may be mostly derived from systemic vasodilatation.
This view is partly supported by the present data that habu venom relaxed isolated aortic ring prepara tions in vitro, and by previous studies in which a weak vasodilating action of habu venom was demonstrated using the perfused rabbit ear preparation (4, 5).
Tachyphylaxis of the hypotensive effect seen when the venom was repeatedly ad ministered implies that the release or for mation of hypotensive substances by habu venom may participate in the hemodynamic effect, as has previously been suggested by Kurihara (5). It is likely that the vasodilating substances such as kinins, histamine, ACh and prostacyclin might be responsible for the hypotensive effect of habu venom. Participa tion of these chemical substances has been reported in various snake venoms: for ex ample, histamine-liberating substances by several snake venoms (11), bradykinin in Bothrops jararaca venom (12) and kinin releasing substances in Bitis arietans (13) and Vipera Aspis Aspis (14). In contrast to these snake venoms, the present data showed that inhibitors of kallikrein, histamine and cyclo oxygenase did not affect the hypotension induced by habu venom. Therefore, the above-mentioned substances seem not to contribute to the hypotensive effect of habu venom in rats. However, since we have ob served in anesthetized dogs that habu venom induced hypotension was markedly reduced by indomethacin (K. Noguchi et al., un published data), it should be noted that there might be a species difference in the hypo tensive effect.
The observation that the hypotension elicited by habu venom was reduced by antivenin suggests the possibility that the hypotensive substance has the enough anti genicity (15, 16). In addition, in this study, the degree of hypotension produced by residual habu venom obtained by dialysis, which would remove the substances with molecular weights of less than 10,000, was comparable to that produced by crude habu venom. These findings also indicate that a component(s) of more than 10,000 molecular weight of crude habu venom causes hy potension.
It has been reported that habu venom contains many substances having molecular weights of more than 10,000 such as proteinase, arginine ester hydrolase, kininogenase, PL-A2 (17-21) and cytotoxic factors (22). PL-A2, kininogenase, and ar ginine ester hydrolase are known to be heat stable components of the venom. In our pre vious study, heated habu venom as well as the non-heated one produced a fall in the coronary perfusion pressure of isolated and perfused rat hearts, indicating that the coro nary vasodilation is related to the action of heat-stable component(s) in crude habu venom (7). In the present study, also, the heat-stable component(s) of habu venom were found to exert a qualitatively similar hemodynamic effect on AoP and the isolated rat aorta preparations precontracted with N E or KCI to the non-heated one. Thus, it can be concluded that the heat-stable component(s) would have an important role in the hypo tension induced by habu venom. Furthermore, the present results showed that heated habu venom produced quantitatively greater vaso relaxation than the non-heated one. This finding suggests that heat-labile com ponent(s) in habu venom have a possible vasoconstrictive activity, which would weak en or disappear after heating.
The fact that hemodynamic changes in duced by habu venom are inhibited by methylprednisolone makes it tempting to speculate that inhibition of PL-A2 activity might be involved in its effect, since methyl prednisolone reduces the activity of PL-A2 (23). This speculation is opposed to the results that the inhibitors of PL-A2 (mepacrine and p-BPB) affected neither the relaxation of the isolated rat aorta preparations induced by non-heated habu venom nor that induced by the heated one, although in the experi ments using egg yolk, both the non-heated habu venom and the heated one had PL-A2 like activity which was reduced by p-BPB. Moreover, the relaxant effect of habu venom in isolated aorta preparations was inhibited neither by inhibitors of cyclooxygenase (indo methacin) and lipoxygenase (NDGA), den udation of the endothelium nor methylene blue. Thus, it is not likely that PL-A2, cyclo oxygenase and lipoxygenase metabolites and the endothelium would participate in a relax ation of the isolated rat aorta. However, there exist some doubts about whether the isolated rat aorta is always a suitable material for evaluating the inhibitory effect on PL-A2 activity.
In addition, the possibility that methylprednisolone might inhibit habu venom induced hypotension unrelated to an activa tion of PL-A2 could not be ruled out com pletely.
